DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr | ₹7,598 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹13,400 Cr |
| Mar2024 | ₹11,786 Cr |
| Mar2023 | ₹10,959 Cr |
| Mar2022 | ₹9,989 Cr |
| Mar2021 | ₹7,598 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,400 Cr | 13.69 | |
| Mar2024 | ₹11,786 Cr | 7.55 | |
| Mar2023 | ₹10,959 Cr | 9.71 | |
| Mar2022 | ₹9,989 Cr | 31.47 | |
| Mar2021 | ₹7,598 Cr | - | |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹166,066.3 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
| MANKIND PHARMA | ₹84,767.5 Cr | -1.1% | -2% | -14.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.5% |
3.3% |
7.9% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses